Alira Health

Four Innovative Areas to Watch in Orthopedic Device Manufacturing

Four Innovative Areas to Watch in Orthopedic Device Manufacturing

As orthopedic procedures and technologies evolve, original equipment manufacturers (OEMs) are increasingly outsourcing production to contract development and manufacturing organizations (CDMOs) to optimize costs, access specialized expertise, and scale production. The orthopedic CDMO market is projected to grow from $11.3 billion today to $15.3 billion by 2028. However, outsourcing levels vary by product category, influenced by factors such as production complexity, regulatory requirements, and competitive pressures.

Following a significant decline in surgical procedures during the COVID-19 pandemic, the orthopedic medical device market experienced a period of inventory normalization in 2023 and 2024, as mid- and large-sized OEMs underwent destocking efforts to adjust after years of supply chain disruptions. However, the orthopedic CDMO market is now poised for a strong rebound. A key driver of this growth is the ongoing shift toward ambulatory surgical centers (ASCs) as alternative surgical settings, fueling an increase in minimally invasive procedures particularly in trauma and sports medicine.

In this article, we explore four innovative areas in orthopedic device manufacturing that are fueling market growth and shaping the surgical landscape today: implants, surgical instruments, cases and trays, and robotic components. 

Orthopedic CDMO Medical Device Market Growth Chart

1. Implants

Outsourcing for implants remains relatively low, particularly among large OEMs who prefer to retain control over the production of high-value, critical components marketed directly to end users. However, smaller OEMs lacking in-house manufacturing capabilities exhibit higher outsourcing rates as they leverage the expertise of CDMOs to accelerate market entry and innovation.

The aging population is contributing to a rising demand for orthopedic implants, further encouraging outsourcing as companies scale production to meet market needs. However, the industry is subject to high regulatory and quality standards, especially in Europe and United States, making it challenging for CDMOs to meet compliance requirements and gain OEM trust. Moreover, pricing pressure and reimbursement challenges continue to impact profitability, making cost efficiency a key consideration for outsourcing decisions.

2. Surgical Instruments

Surgical instruments are extensively outsourced due to their inherent complexity, requiring specialist manufacturing techniques such as precision machining, finishing, and assembly. This demand is further driven by the ongoing increase in orthopedic surgeries, encouraging OEMs to rely on outsourcing partners for production scalability. Single use surgical instruments are also fueling market growth. They improve operating room efficiency and turnover, minimize inventory levels, and reduce equipment, lifecycle, and reprocessing costs. These instruments are typically made from plastic, making them more commonly used in extremities. ASCs are also projected to play a role in adoption of single use instruments because of limited space and resources.

Despite overall market growth, the industry is experiencing slight price erosion, which pressures profit margins for both OEMs and CDMOs. At the same time, the rise of single-use instruments introduces unique challenges. Surgeon concerns about their reliability may slow adoption, and meeting manufacturing standards can be demanding. In particular, manufacturers must have medical-grade plastic capabilities to meet OEM requirements for single-use instrumentation.

3. Cases and Trays

Cases and trays are some of the most outsourced components in the orthopedics market. As the number of orthopedic surgeries increases, so does the demand for these items. Traditional cases and trays, however, face slight price erosion, making it difficult for CDMOs to maintain margins and differentiate their offerings.

Innovations in materials and packaging help manufacturers produce cases and trays that are more durable, functional, and cost-effective. Building on these advances, design trends have shifted toward custom trays that can significantly reduce the operating room footprint, improve surgical comfort, and lower adoption barriers.

A strong focus on advanced manufacturing techniques, material versatility, and specialized support is essential to meet the evolving demands of OEMs. To stay competitive, CDMOs have expanded beyond standard production capabilities.

4. Robotic Components

A niche but growing segment, robotic components present unique challenges due to the need for extremely tight tolerances and high precision. While outsourcing rates are moderate, OEMs tend to partner with a limited number of trusted CDMOs capable of meeting stringent quality and performance requirements. This collaboration ensures consistency in outsourcing demand for the highly specialized field of robotic-assisted surgical systems. Additionally, advancements in miniaturization and sensor technology are further driving the need for specialized manufacturing expertise in this space.

Conclusion

As the orthopedic device market continues to expand, fueled by the shift toward ASCs, advances in surgical techniques, and increased outsourcing, CDMOs stand at the forefront of transformative growth. The four manufacturing areas explored in this article underscore the industry’s evolution, while emerging design innovations hint at a more connected and efficient future. For CDMOs and OEMs alike, success hinges on strategic partnerships, investment in specialized capabilities, and an agile approach to meet the rising demands of both patients and providers. By understanding where the market is headed, stakeholders can better position themselves to lead in this rapidly advancing therapeutic area.

For more insights, download the 2026 Global Medtech Contract Development and Manufacturing Report.

Expert insights
provided by:

Sofia Puzzi

Sofia Puzzi, Principal, Transaction Advisory

Eve Ogdon, Consultant, Management Consulting

Mololuwa Oluwajobi, Senior Associate, Transaction Advisory

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.